Jiangsu Hengrui reported CNY2.78B in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Kangmei Pharma CNY 237.06M 37.35M Mar/2026
Sh Fosun Pharma CNY 3.35B 74.31M Jun/2026
Sh Pharmaceutical CNY 4.69B 96.06M Jun/2026
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Wuxi Apptec CNY 989.51M 97.71M Jun/2026
Zz Pientze Pharmaceu CNY 223.14M 8.82M Jun/2026